- Mr Simon Brewin
- Mr Andrew Cowlishaw
- Professor Andrew Cuthbertson AO
- Ms Christine Edwards
- Ms Olivia Hilton (Chair)
- Mr Peter Larsen
- Professor Keith Martin
- Ms Wendy Miller
Mr Simon Brewin
B Bus, Grad Dip HSM, MBL, FCHSM, GAICD
Simon is an experienced non-executive director with expertise in governance, infrastructure and project management. Over a 35 year period he held executive roles at a number of Melbourne health organisations with a portfolio responsibility for strategic and service planning, clinical and non-clinical services, infrastructure, facilities and project management.
Simon was appointed to the board of the Royal Victorian Eye and Ear hospital in July 2017 and is Chair of the Audit and Risk Committee and member of the quality Committee. He is a Fellow of the Australasian College of Health Service Management (past president Victorian Branch) and a Graduate of the Australia Institute of Company Directors.
Mr Andrew Cowlishaw
B.Comm (Accounting and Finance), CA (Chair of Finance and Risk, Treasurer)
Andrew Cowlishaw is an experienced finance executive, with 18 years’ experience across corporate finance, strategy and operations. He is a Partner of Ernst & Young, where he leads the Melbourne Mergers & Acquisitions practice group. Andrew focuses on the healthcare, education and financial sponsors industry sectors. He has been a non-executive director of numerous private high growth companies and has worked extensively with management teams and boards in setting strategies and driving operational improvements.
Professor Andrew Cuthbertson AO
Professor Cuthbertson is Chief Scientific Officer and Director, Research and Development for CSL Limited. In 2016 he was made an Enterprise Professor, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne and an Officer of the Order of Australia for his services to medical research.
Ms Christine Edwards
Ba. Soc. Sc., Post Grad. Cert. Public Sector Management, M. Health Admin
Christine has extensive experience in the health, community and philanthropic sectors in Western Australia, Tasmania and Victoria. Christine has been the CEO of two hospitals in Victoria, leading the delivery of aged and palliative care services. Christine is currently a consultant in philanthropy, and most recently was the Chief Executive Officer of The Myer Foundation and Sidney Myer Fund. Christine holds a number of Directorship and Advisory positions, and provides strategic philanthropic advice to community-based organisations.
Ms Olivia Hilton (Chair)
Olivia is a current Partner at Social Ventures Australia (SVA) Consulting. Olivia has deep experience supporting organisations who are driving social change on issues of strategy, measurement and evaluation and governance. Olivia is a former CEO of an Australian publicly listed communications company, where she devised, led and managed the company’s strategy and day-to-day operations, including a staff of 100 employees in five countries. She has extensive experience in strategy development, implementation, communications and operations.
Mr Peter Larsen
Peter Larsen is a Director of Professional Services, Specsavers Australia and New Zealand and Dermox Pty Ltd. After graduating with a Bachelor of Optometry from the University of Melbourne in 1987 he spent time in England working in a variety of optometry practices, returning to Australia 1993. Since 1995, Peter has successfully developed a number of businesses within the ophthalmic industry.
At the start of 2007, Peter left his role as Optovision Managing Director to become Managing Director for Specsavers Australia.
Professor Keith Martin
MA BM BCh DM MRCP FRCOphth FRANZCO ALCM
Keith Martin is Managing Director of the Centre for Eye Research Australia and Ringland Anderson Professor and Head of Ophthalmology at the University of Melbourne.
Until January 2019, he was Head of Ophthalmology at the University of Cambridge, Deputy Director of the University’s John van Geest Centre for Brain Repair and an Affiliate Principal Investigator at the Wellcome Trust – MRC Cambridge Stem Cell Institute. He was also Academic Lead for Ophthalmology and Lead Clinician for Glaucoma at the Cambridge University Hospitals NHS Foundation Trust.
He graduated from the University of Cambridge with a ‘Triple First’ in Medical Sciences and Neuroscience before completing clinical Training at Oxford University Clinical School, Ophthalmology Residency in Cambridge and Clinical and Research Fellowships in Glaucoma at Moorfields Eye Hospital in London and the Wilmer Eye Institute in Baltimore.
Professor Martin is working to develop new treatments for eye disease using stem cells, gene therapy and other techniques. In 2010, Professor Martin won the ARVO Foundation for Eye Research Translational Research Award, an international prize to a researcher from any country under the age of 50 years whose research is judged to have the potential to lead to major breakthroughs in the treatment of eye disease. He was also a winner of the World Glaucoma Association Senior Clinician Scientist Award in 2011 and was awarded the Duke Elder Medal by the Royal College of Ophthalmologists in 2017.
He is co-founder of Quethera, a Cambridge-based gene therapy company which has developed a gene therapy for glaucoma that is currently progressing towards human clinical trials. His other current main research interest is in the potential for regeneration and repair of nerve damage in the eye and brain.
Clinically, Professor Martin specialises in the medical and surgical management of complex glaucoma. He is currently President of the World Glaucoma Association, the largest glaucoma organisation in the world.
Ms Wendy Miller
BA, LLB (Hons)
Wendy Miller is a practising lawyer with close to 10 years’ experience in corporate and commercial law. She is an expert in governance, contracting, partnerships and compliance. Wendy was previously a director of the Victorian Deaf Society and is currently a governance and legal adviser at the Australian Centre for the Moving Image.